I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
McGarry, Lisa J
110
results:
Search for persons
X
Format
Online (110)
Mediatypes
Articles (Online) (60)
Bookchapter (Online) (1)
OpenAccess-fulltext (49)
Sorted by: Relevance
Sorted by: Year
?
1
Psychometric performance of the CFQ-R-8D compared to the EQ..:
Mukuria, Clara
;
Rowen, Donna
;
Acaster, Sarah
...
Journal of Patient-Reported Outcomes. 8 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
2
Cystic fibrosis patient characteristics and healthcare reso..:
Malmivaara, Kirsi
;
Pölkki, Mari
;
Prami, Tuire
...
Heliyon. 10 (2024) 13 - p. e33439 , 2024
Link:
https://doi.org/10.1016/..
?
3
Clinical, economic, and societal burden of cystic fibrosis ..:
Lindblad, Anders
;
Monestrol, Isabelle de
;
Gilljam, Marita
...
Journal of Medical Economics. 27 (2024) 1 - p. 897-906 , 2024
Link:
https://doi.org/10.1080/..
?
4
Impact of age at ivacaftor initiation on pulmonary outcomes..:
Merlo, Christian A
;
McGarry, Lisa J
;
Thorat, Teja
...
Thorax. , 2024
Link:
https://doi.org/10.1136/..
?
5
Long-term impact of ivacaftor on mortality rate and health ..:
Merlo, Christian A
;
Thorat, Teja
;
DerSarkissian, Maral
...
Thorax. , 2024
Link:
https://doi.org/10.1136/..
?
6
Education, employment, and income among people living with ..:
Jensen, Camilla Bjørn
;
Jensen, Kristoffer Jarlov
;
Pressler, Tacjana
...
Journal of Cystic Fibrosis. , 2024
Link:
https://doi.org/10.1016/..
?
7
Calibration and validation of modeled 5-year survival predi..:
McGarry, Lisa J.
;
Bhaiwala, Zahra
;
Lopez, Andrea
...
PLOS ONE. 18 (2023) 4 - p. e0283479 , 2023
Link:
https://doi.org/10.1371/..
?
8
EFFECT OF ELEXACAFTOR/TEZACAFTOR/IVACAFTOR ON ANNUAL RATE O..:
Lee, Tim
;
Sawicki, Gregory S.
;
Altenburg, Josje
...
Journal of Cystic Fibrosis. 22 (2023) 3 - p. 402-406 , 2023
Link:
https://doi.org/10.1016/..
?
9
Development of the Cystic Fibrosis Questionnaire-Revised-8 ..:
Acaster, Sarah
;
Mukuria, Clara
;
Rowen, Donna
...
Value in Health. 26 (2023) 4 - p. 567-578 , 2023
Link:
https://doi.org/10.1016/..
?
10
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Re..:
Schechter, Michael S.
;
Sabater-Anaya, Natalia
;
Oster, Gerry
...
Pulmonary Therapy. 9 (2023) 4 - p. 479-498 , 2023
Link:
https://doi.org/10.1007/..
?
11
Healthcare resource utilization and costs among children wi..:
Thorat, Teja
;
McGarry, Lisa J.
;
Bonafede, Machaon M.
...
Pediatric Pulmonology. 56 (2021) 9 - p. 2833-2844 , 2021
Link:
https://doi.org/10.1002/..
?
12
Long-Term Impact of Ivacaftor on Healthcare Resource Utiliz..:
Thorat, Teja
;
McGarry, Lisa J.
;
Jariwala-Parikh, Krutika
...
Pulmonary Therapy. , 2021
Link:
https://doi.org/10.1007/..
?
13
Real-World Outcomes of Ivacaftor Treatment in People with C..:
Duckers, Jamie
;
Lesher, Beth
;
Thorat, Teja
...
Journal of Clinical Medicine. 10 (2021) 7 - p. 1527 , 2021
Link:
https://doi.org/10.3390/..
?
14
The Cystic Fibrosis Impact Questionnaire: qualitative devel..:
McCarrier, Kelly P.
;
Hassan, Mariam
;
Hodgkins, Paul
...
Journal of Patient-Reported Outcomes. 4 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
15
Cost Effectiveness of the Third-Generation Tyrosine Kinase ..:
Hirt, Carsten
;
Iannazzo, Sergio
;
Chiroli, Silvia
...
Applied Health Economics and Health Policy. 17 (2019) 4 - p. 555-567 , 2019
Link:
https://doi.org/10.1007/..
1-15